The First Republic Investment Management Inc. Acquires 8,367 Shares of Northern Trust Corporation (NTRS)

The First Republic Investment Management Inc. Acquires 8,367 Shares of Northern Trust Corporation (NTRS)

First Republic Investment Management Inc. boosted its stake in Northern Trust Corporation (NASDAQ:NTRS) by 6.3% during the fourth quarter, Holdings Channel reports. The firm owned 141,090 shares of the company’s stock after buying an additional 8,367 shares during the period. First Republic Investment Management Inc.’s holdings in Northern Trust Corporation were worth $12,565,000 as of its most recent SEC filing. Other large investors have also recently added to or reduced their stakes in the company. FIL Ltd purchased a new stake in Northern Trust Corporation during the fourth quarter valued…

The William Blair Investment Management LLC Raises Position in Repligen Corporation (RGEN)

The William Blair Investment Management LLC Raises Position in Repligen Corporation (RGEN)

William Blair Investment Management LLC boosted its position in Repligen Corporation (NASDAQ:RGEN) by 0.9% during the fourth quarter, Holdings Channel reports. The fund owned 676,733 shares of the company’s stock after buying an additional 5,820 shares during the period. William Blair Investment Management LLC’s holdings in Repligen Corporation were worth $20,857,000 as of its most recent filing with the SEC. Other institutional investors have also recently made changes to their positions in the company. Teacher Retirement System of Texas raised its position in shares of Repligen Corporation by 21.2% in…

The Informa Plc (INF) Receives Consensus Rating of “Buy” from Analysts

The Informa Plc (INF) Receives Consensus Rating of “Buy” from Analysts

Shares of Informa Plc (LON:INF) have earned an average recommendation of “Buy” from the eighteen analysts that are presently covering the firm. One analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is GBX 766.67 ($9.55). A number of research analysts have weighed in on the stock. Liberum Capital reissued a “hold” rating and issued…

The CBOE Holdings, Inc. (CBOE) Receives Consensus Recommendation of “Hold” from Analysts

The CBOE Holdings, Inc. (CBOE) Receives Consensus Recommendation of “Hold” from Analysts

CBOE Holdings, Inc. (NASDAQ:CBOE) has been given a consensus rating of “Hold” by the seventeen research firms that are covering the firm. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $69.37. CBOE has been the subject of a number of analyst reports. Bank of America Corp raised CBOE Holdings…

The 4,153 Shares in Realty Income Corp (O) Acquired by Moloney Securities Asset Management LLC

The 4,153 Shares in Realty Income Corp (O) Acquired by Moloney Securities Asset Management LLC

Moloney Securities Asset Management LLC acquired a new stake in Realty Income Corp (NYSE:O) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,153 shares of the company’s stock, valued at approximately $239,000. Other large investors also recently bought and sold shares of the company. Evercore Wealth Management LLC boosted its stake in shares of Realty Income Corp by 7.7% in the second quarter. Evercore Wealth Management LLC now owns 5,006 shares of the company’s stock valued at $348,000…

The Curtiss-Wright Corporation (CW) Shares Sold by William Blair Investment Management LLC

The Curtiss-Wright Corporation (CW) Shares Sold by William Blair Investment Management LLC

William Blair Investment Management LLC lowered its stake in shares of Curtiss-Wright Corporation (NYSE:CW) by 21.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 198,854 shares of the company’s stock after selling 55,705 shares during the period. William Blair Investment Management LLC’s holdings in Curtiss-Wright Corporation were worth $19,559,000 at the end of the most recent reporting period. Several other institutional investors have also recently made changes to their positions in CW. BlackRock Fund Advisors boosted its…

The UNICREDIT SPA NPV (POST REV SPLIT) (UNCFF) Receives Consensus Rating of “Buy” from Brokerages

The UNICREDIT SPA NPV (POST REV SPLIT) (UNCFF) Receives Consensus Rating of “Buy” from Brokerages

UNICREDIT SPA NPV (POST REV SPLIT) (OTCMKTS:UNCFF) has been assigned an average rating of “Buy” from the eight ratings firms that are currently covering the firm. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Several analysts have recently commented on the company. Berenberg Bank upgraded UNICREDIT SPA NPV (POST REV SPLIT) from a “hold” rating to a “buy” rating in a report on Thursday. RBC Capital Markets upgraded UNICREDIT SPA NPV (POST REV SPLIT) from a…

The CONMED Corporation (CNMD) Shares Sold by William Blair Investment Management LLC

The CONMED Corporation (CNMD) Shares Sold by William Blair Investment Management LLC

William Blair Investment Management LLC reduced its stake in shares of CONMED Corporation (NASDAQ:CNMD) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 437,254 shares of the medical technology company’s stock after selling 2,502 shares during the period. William Blair Investment Management LLC’s holdings in CONMED Corporation were worth $19,314,000 as of its most recent filing with the SEC. Other hedge funds have also added to or reduced their stakes in the company. Teacher Retirement System of Texas…

The Heron Therapeutics, Inc. (HRTX) Stake Cut by Franklin Resources Inc.

The Heron Therapeutics, Inc. (HRTX) Stake Cut by Franklin Resources Inc.

Franklin Resources Inc. reduced its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) by 0.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 7,685,568 shares of the biotechnology company’s stock after selling 50,280 shares during the period. Franklin Resources Inc.’s holdings in Heron Therapeutics were worth $100,669,000 as of its most recent SEC filing. Several other institutional investors have also recently added to or reduced their stakes in HRTX. Pacad Investment Ltd. purchased a new position in Heron Therapeutics during the…

The Auto Trader Group PLC (AUTO) Receives Average Rating of “Buy” from Analysts

The Auto Trader Group PLC (AUTO) Receives Average Rating of “Buy” from Analysts

Shares of Auto Trader Group PLC (LON:AUTO) have received an average rating of “Buy” from the fourteen brokerages that are currently covering the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating and ten have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is GBX 460.86 ($5.74). AUTO has been the subject of several research reports. Goldman Sachs Group, Inc. (The) reiterated a “buy”…

The Potbelly Corporation (PBPB) Position Decreased by GSA Capital Partners LLP

The Potbelly Corporation (PBPB) Position Decreased by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its stake in shares of Potbelly Corporation (NASDAQ:PBPB) by 0.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,898 shares of the company’s stock after selling 602 shares during the period. GSA Capital Partners LLP’s holdings in Potbelly Corporation were worth $1,882,000 at the end of the most recent reporting period. Several other institutional investors also recently bought and sold shares of the stock. Nicholas Co. Inc. WI bought a new…

The GSA Capital Partners LLP Purchases Shares of 14,784 Palo Alto Networks, Inc. (PANW)

The GSA Capital Partners LLP Purchases Shares of 14,784 Palo Alto Networks, Inc. (PANW)

GSA Capital Partners LLP bought a new position in shares of Palo Alto Networks, Inc. (NYSE:PANW) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 14,784 shares of the network technology company’s stock, valued at approximately $1,849,000. Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Fred Alger Management Inc. raised its position in Palo Alto Networks by 142.5% in the fourth quarter. Fred Alger Management Inc. now owns 502,393 shares of the network…

The Two Sigma Investments LP Increases Position in Equity One, Inc. (EQY)

The Two Sigma Investments LP Increases Position in Equity One, Inc. (EQY)

Two Sigma Investments LP boosted its stake in shares of Equity One, Inc. (NYSE:EQY) by 3,701.9% during the fourth quarter, Holdings Channel reports. The firm owned 493,452 shares of the real estate investment trust’s stock after buying an additional 480,473 shares during the period. Two Sigma Investments LP’s holdings in Equity One were worth $15,144,000 at the end of the most recent quarter. A number of other large investors have also recently made changes to their positions in the stock. A.R.T. Advisors LLC purchased a new stake in shares of…

The Dynavax Technologies Corporation (DVAX) Given Average Rating of “Hold” by Brokerages

The Dynavax Technologies Corporation (DVAX) Given Average Rating of “Hold” by Brokerages

Shares of Dynavax Technologies Corporation (NASDAQ:DVAX) have been given an average recommendation of “Hold” by the seven analysts that are presently covering the company. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $20.17. DVAX has been the subject of several analyst reports. William Blair restated an “outperform” rating and issued a $17.00 target price (down from $45.00)…

The Nokia Corporation (NOK) Now Covered by Craig Hallum

The Nokia Corporation (NOK) Now Covered by Craig Hallum

Investment analysts at Craig Hallum started coverage on shares of Nokia Corporation (NYSE:NOK) in a report issued on Tuesday. The firm set a “buy” rating and a $7.50 price target on the technology company’s stock. Craig Hallum’s price objective would suggest a potential upside of 47.06% from the company’s current price. NOK has been the topic of several other research reports. Canaccord Genuity reiterated a “buy” rating and issued a $5.50 price objective (down previously from $6.00) on shares of Nokia Corporation in a research note on Friday, October 28th….

The TheStreet Upgrades Liberty Global PLC (LBTYA) to “C”

The TheStreet Upgrades Liberty Global PLC (LBTYA) to “C”

Liberty Global PLC (NASDAQ:LBTYA) was upgraded by equities researchers at TheStreet from a “d+” rating to a “c” rating in a research report issued to clients and investors on Friday. LBTYA has been the subject of a number of other reports. Zacks Investment Research raised Liberty Global PLC from a “hold” rating to a “buy” rating and set a $35.00 price target for the company in a report on Tuesday, December 27th. Macquarie reaffirmed a “buy” rating and issued a $42.00 price target on shares of Liberty Global PLC in…

The TransCanada Co. (TRP) Rating Reiterated by Royal Bank Of Canada

The TransCanada Co. (TRP) Rating Reiterated by Royal Bank Of Canada

TransCanada Co. (TSE:TRP) (NYSE:TRP)‘s stock had its “outperform” rating restated by analysts at Royal Bank Of Canada in a research note issued to investors on Thursday, StockTargetPrices.com reports. They presently have a C$72.00 target price on the stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 16.02% from the stock’s previous close. Several other equities analysts have also commented on TRP. National Bank Financial raised their price objective on TransCanada from C$63.00 to C$66.00 in a research report on Wednesday, January 25th. TD Securities raised their…

The Shires Income plc Announces Dividend of GBX 3 (SHRS)

The Shires Income plc Announces Dividend of GBX 3 (SHRS)

Shires Income plc (LON:SHRS) announced a dividend on Thursday, February 23rd. Investors of record on Thursday, April 6th will be paid a dividend of GBX 3 ($0.04) per share on Friday, April 28th. This represents a dividend yield of 1.28%. The ex-dividend date of this dividend is Thursday, April 6th. The official announcement can be viewed at this link. Shares of Shires Income plc (LON:SHRS) remained flat at GBX 234.50 during mid-day trading on Thursday. The stock had a trading volume of 47,504 shares. The company’s 50 day moving average…

The Analysts Issue Forecasts for Canadian Imperial Bank of Commerce’s Q1 2017 Earnings (CM)

The Analysts Issue Forecasts for Canadian Imperial Bank of Commerce’s Q1 2017 Earnings (CM)

Canadian Imperial Bank of Commerce (TSE:CM) (NYSE:CM) – Research analysts at National Bank Financial issued their Q1 2017 earnings per share (EPS) estimates for shares of Canadian Imperial Bank of Commerce in a research report issued to clients and investors on Monday. National Bank Financial analyst G. Dechaine forecasts that the firm will post earnings of $2.53 per share for the quarter. National Bank Financial currently has a “Outperform” rating on the stock. National Bank Financial also issued estimates for Canadian Imperial Bank of Commerce’s Q2 2017 earnings at $2.59…

The FY2020 Earnings Estimate for Theravance Biopharma, Inc. (TBPH) Issued By Leerink Swann

The FY2020 Earnings Estimate for Theravance Biopharma, Inc. (TBPH) Issued By Leerink Swann

Theravance Biopharma, Inc. (NASDAQ:TBPH) – Research analysts at Leerink Swann issued their FY2020 EPS estimates for shares of Theravance Biopharma in a research report issued on Tuesday. Leerink Swann analyst G. Porges expects that the firm will earn $2.71 per share for the year. Leerink Swann has a “Buy” rating and a $33.00 price objective on the stock. Leerink Swann also issued estimates for Theravance Biopharma’s FY2021 earnings at ($1.31) EPS. A number of other equities research analysts have also commented on TBPH. Piper Jaffray Companies assumed coverage on Theravance…